UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$948M |
| 2 |
Snowflake
SNOW
|
+$542M |
| 3 |
Sea Limited
SE
|
+$501M |
| 4 |
Procter & Gamble
PG
|
+$491M |
| 5 |
Snap
SNAP
|
+$403M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Infosys
INFY
|
+$434M |
| 2 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$350M |
| 3 |
Lowe's Companies
LOW
|
+$215M |
| 4 |
Applied Materials
AMAT
|
+$186M |
| 5 |
MXIM
Maxim Integrated Products
MXIM
|
+$183M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.21% |
| 2 | Healthcare | 13.25% |
| 3 | Financials | 13.07% |
| 4 | Consumer Discretionary | 12.28% |
| 5 | Communication Services | 10.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CIVI
2326
DELISTED
Civitas Resources
CIVI
| $656K | ﹤0.01% |
13,692
-1,788
| -12% | -$73.2K |
|
2327
Clover Health Investments
CLOV
$2.51B
| $656K | ﹤0.01% |
88,722
| – | – |
|
2328
Stoneridge
SRI
$213M
| $655K | ﹤0.01% |
32,115
| – | – |
|
2329
BioXcel Therapeutics
BTAI
$27.8M
| $653K | ﹤0.01% |
1,345
+57
| +4% | +$25.1K |
|
2330
Groupon
GRPN
$1.02B
| $652K | ﹤0.01% |
28,592
+6,327
| +28% | +$187K |
|
|
CCF
2331
DELISTED
Chase Corporation
CCF
| $650K | ﹤0.01% |
6,367
+1,120
| +21% | +$125K |
|
|
CTEV
2332
Claritev Corp
CTEV
$556M
| $650K | ﹤0.01% |
2,885
| – | – |
|
|
SHOE
2333
Shoe Station Group
SHOE
$428M
| $649K | ﹤0.01% |
20,031
+4,959
| +33% | +$173K |
|
|
CTT
2334
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $648K | ﹤0.01% |
54,622
-6,306
| -10% | -$73.5K |
|
2335
Star Group
SGU
$423M
| $647K | ﹤0.01% |
63,464
| – | – |
|
2336
Amphastar Pharmaceuticals
AMPH
$916M
| $647K | ﹤0.01% |
34,016
-9,795
| -22% | -$192K |
|
2337
Hackett Group
HCKT
$287M
| $646K | ﹤0.01% |
32,922
+360
| +1% | +$6.74K |
|
2338
Hyliion Holdings
HYLN
$690M
| $644K | ﹤0.01% |
76,716
| – | – |
|
|
KBAL
2339
DELISTED
Kimball International
KBAL
| $644K | ﹤0.01% |
57,522
| – | – |
|
2340
Axogen
AXGN
$2.5B
| $644K | ﹤0.01% |
40,741
| – | – |
|
2341
CVR Energy
CVI
$3.13B
| $642K | ﹤0.01% |
38,556
| – | – |
|
|
AVTA
2342
DELISTED
Avantax, Inc. Common Stock
AVTA
| $642K | ﹤0.01% |
41,161
| – | – |
|
2343
Myers Industries
MYE
$1.29B
| $640K | ﹤0.01% |
32,714
| – | – |
|
2344
PetMed Express
PETS
$42.3M
| $640K | ﹤0.01% |
23,815
+4,862
| +26% | +$140K |
|
|
EBIX
2345
DELISTED
Ebix Inc
EBIX
| $639K | ﹤0.01% |
23,736
| – | – |
|
|
TRHC
2346
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $639K | ﹤0.01% |
24,377
+2,710
| +13% | +$99.8K |
|
2347
OneSpan
OSPN
$618M
| $636K | ﹤0.01% |
33,874
| – | – |
|
2348
Tactile Systems Technology
TCMD
$665M
| $634K | ﹤0.01% |
14,260
+193
| +1% | +$8.68K |
|
2349
Energy Recovery
ERII
$443M
| $631K | ﹤0.01% |
33,177
+407
| +1% | +$8.26K |
|
2350
Argan
AGX
$8.37B
| $631K | ﹤0.01% |
14,456
+1,900
| +15% | +$85.9K |
|
Similar funds
UBS AM's Q3 2021 Portfolio in Review
As of Q3 2021, UBS AM held 2,809 positions worth $241B, up 3.2% from $234B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
UBS AM deployed $8.13B of net new capital in Q3 2021, opening 56 new positions and adding to 1,358 existing holdings. Its largest new stake was State Street SPDR Portfolio Intermediate Term Treasury ETF: 6,053,315 shares worth $196M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Infosys, an estimated $434M trimmed.
- UBS AM's largest Q3 2021 buy was State Street SPDR Portfolio Intermediate Term Treasury ETF: 6,053,315 shares worth $196M.
- UBS AM added most to Microsoft in Q3 2021, an estimated $948M increase.
- UBS AM's biggest Q3 2021 reduction was Infosys, cutting an estimated $434M.
- UBS AM fully exited Vanguard Short-Term Treasury ETF in Q3 2021, selling an estimated $350M.
- UBS AM's ten largest holdings make up 22% of its $241B portfolio in Q3 2021.
- UBS AM opened 56 new positions and closed 62 in Q3 2021.
- UBS AM's portfolio value rose 3.2% quarter-over-quarter to $241B.
Based on UBS AM's 13F filing for Q3 2021, filed 15 Nov 2021.